SCHEMBL23213647

SCHEMBL23213647

Cc1ccc(S(=O)(=O)OCCC(CCOS(=O)(=O)c2ccc(C)cc2)c2cc(F)ccc2OCc2ccccc2)cc1.OCCC(CCO)c1cc(F)ccc1OCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 6/20 0.42
NFE2L2 Q16236 6/20 0.42
LMNA P02545 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
RECQL P46063 1/20 0.39
FFAR4 Q5NUL3 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.37
CYP19A1 P11511 1/20 0.37
AKR1C3 P42330 1/20 0.36
SGMS2 Q8NHU3 1/20 0.36
SLC6A9 P48067 1/20 0.36
SLC6A5 Q9Y345 1/20 0.36
AR P10275 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23210311 0.95 LMNA (0.44) KEAP1NFE2L2LMNACYP1A2CYP2C9
SCHEMBL23212912 0.93 KEAP1 (0.42) KEAP1NFE2L2LMNACYP1A2CYP2C9
SCHEMBL23213167 0.90 KEAP1 (0.43) KEAP1NFE2L2LMNACYP1A2CYP2C9
SCHEMBL23210226 0.88 LMNA (0.44) KEAP1NFE2L2LMNACYP1A2CYP2C9
SCHEMBL23209991 0.85 LMNA (0.48) KEAP1NFE2L2LMNACYP1A2CYP2C9
SCHEMBL23213491 0.84 LMNA (0.42) KEAP1NFE2L2LMNACYP1A2CYP2C9
SCHEMBL29619704 0.82 SLC6A9 (0.45) LMNAMAPTFFAR4MRGPRX4AKR1C3
SCHEMBL23210176 0.82 SLC6A9 (0.45) LMNAMAPTFFAR4MRGPRX4AKR1C3
SCHEMBL23213273 0.81 KDM1A (0.40) KEAP1NFE2L2LMNACYP1A2CYP2C9
SCHEMBL23212923 0.80 PSEN1 (0.38) LMNAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021070091-A1 5-OXA-2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS NOVARTIS AG (CH) 2021-04-15 WO disclosed
WO-2021070090-A1 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS NOVARTIS AG (CH) 2021-04-15 WO disclosed